Back to OYSTView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Dry Eye Disease
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
OC-01 Low Dose, 0.12 mg/mLPhase 3
Long Term Follow up Dry Eye Disease
OC-01 (varenicline) nasal sprayPhase 3
Dry Eye Disease (DED)
Varenicline Tartrate Nasal SprayPhase 3
Dry Eye Disease
OC-01 (varenicline) nasal spray 1.2 mg/mlPhase 2
Neurotrophic Keratopathy
OC-01 0.1% 0.6 mg/mlPhase 2
Dry Eye Disease
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts